Self-reported depressive symptoms in association with medication exposures among medical inpatients: a cross-sectional study

Can J Psychiatry. 1995 Jun;40(5):264-9.

Abstract

Objective: To evaluate associations between exposure to three classes of medications (angiotensin converting enzyme inhibitors, calcium channel blockers, and corticosteroids) and self-reported depressive symptoms.

Method: The study utilised a cross-sectional study design in a sample of medical inpatients.

Results: Associations between self-reported depressive symptoms and exposure to angiotensin converting enzyme inhibitors or calcium channel blockers were not observed. However, an association between self-reported depressive symptoms and corticosteroid exposure was identified. The association was strongest in subjects reporting a past history of depression or a family history of depression. The strength of the corticosteroid-depressive symptom association was comparable with that of associations observed for age, poverty and psychosocial stress.

Conclusions: Depressive symptoms among medical inpatients have a biopsychosocial etiology. Corticosteroid exposure may be a biological risk factor for depressive symptoms in this population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / adverse effects*
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Calcium Channel Blockers / adverse effects*
  • Calcium Channel Blockers / therapeutic use
  • Cross-Sectional Studies
  • Depression / chemically induced*
  • Depression / genetics
  • Depression / psychology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Care Team*
  • Personality Assessment
  • Risk Factors
  • Sick Role*
  • Socioeconomic Factors
  • Stress, Psychological / complications

Substances

  • Adrenal Cortex Hormones
  • Angiotensin-Converting Enzyme Inhibitors
  • Calcium Channel Blockers